NCT00880360: A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer |
|
|
| Completed | 2 | 19 | US | Ontak, Denileukin Diftitox | The University of Texas Health Science Center at San Antonio | Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer, Fallopian Tube Carcinoma | 04/10 | 04/10 | | |
NCT01773889: A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer |
|
|
| Terminated | 2 | 2 | US | Denileukin Diftitox/SC Pegylated IFNα-2a, Ontak plus Pegylated IFNα-2a | The University of Texas Health Science Center at San Antonio | Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer, Fallopian Tube Carcinoma | 06/11 | 06/11 | | |
